Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects-Reference-Cited by-同舟云学术

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects

Published:2021-11-22 Issue: Volume: Page:
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharmacol Ther

Author:

Becker Anna M.¹²³,Holze Friederike¹²³,Grandinetti Tanja¹²³,Klaiber Aaron¹²³,Toedtli Vanja E.¹²³,Kolaczynska Karolina E.¹²³,Duthaler Urs¹²³^ORCID,Varghese Nimmy⁴⁵^ORCID,Eckert Anne⁴⁵,Grünblatt Edna⁶⁷⁸,Liechti Matthias E.¹²³^ORCID

Affiliation:

1. Clinical Pharmacology and Toxicology Department of Biomedicine University Hospital Basel University of Basel Basel Switzerland

2. Department of Clinical Research University Hospital Basel University of Basel Basel Switzerland

3. Department of Pharmaceutical Sciences University of Basel Basel Switzerland

4. Psychiatric University Hospital University of Basel Basel Switzerland

5. Transfaculty Research Platform Molecular and Cognitive Neuroscience University of Basel Basel Switzerland

6. Department of Child and Adolescent Psychiatry and Psychotherapy Psychiatric Hospital University of Zurich Zurich Switzerland

7. Neuroscience Center Zurich University of Zurich and ETH Zurich Zurich Switzerland

8. Zurich Center for Integrative Human Physiology University of Zurich Zurich Switzerland

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2487

Reference52 articles.

1. Trial of Psilocybin versus Escitalopram for Depression

2. Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression

3. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

4. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

5. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in blood;European Neuropsychopharmacology;2024-10

2. Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom ( Psilocybe cubensis ): A Systematic Review;Journal of Psychoactive Drugs;2024-09-10

3. Shared effects of electroconvulsive shocks and ketamine on neuroplasticity: A systematic review of animal models of depression;Neuroscience & Biobehavioral Reviews;2024-09

4. The role of psilocybin in depressive disorders;Current Medical Research and Opinion;2024-08-28

5. Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label Study;2024-08-23